(Aemetis/Globe Newswire) Finalizing Grant for “Valorizing Forest Waste for Cellulosic Ethanol Production” to Extract Sugars from Waste Forest and Orchard Wood Using Ionic Liquids Technology Licensed Exclusively to Aemetis from DOE-Funded Joint BioEnergy Institute (JBEI) Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, has been notified of a grant from the U.S. Forest Service toward the commercialization of a patented process that extracts cellulosic sugars from waste orchard wood, waste forest wood, and other biomass.
The sugars from waste wood could potentially be used to produce high value cellulosic ethanol at the existing 65 million gallon per year Aemetis ethanol plant, while the remaining lignin material is expected to be used in the production of negative carbon intensity, cellulosic hydrogen for use in renewable jet and diesel production at the Aemetis Carbon Zero 1 plant being built in
Extensive Usage of Isoprenol in Agrochemical & Pharmaceutical Industry to Push Sales: Fact.MR
NEW YORK, May 19, 2021 /PRNewswire/ The global isoprenol market is projected to grow at an impressive pace at around 6.5% CAGR though 2031, estimates Fact.MR. The market will gain traction through 2031 due to the advancements in manufacturing sector coupled with the increasing application of isoprenol in agrochemical & pharmaceutical industry. Rise in application in fragrance & flavors and pharmaceutical industry is expected to raise the revenue of isoprenol manufacturers in the upcoming decade.
According to Fact.MR, growing research & development activities by manufacturers for sustainable usage of isoprenol will aid in industry growth over the coming years. Extensive usage of isoprenol in the development of insecticides, production of pesticides and building block of aromatic ingredients is accelerating the growth of isoprenol market. The ever expanding agrochemical and pharmaceutical
Extensive Usage of Isoprenol in Agrochemical & Pharmaceutical Industry to Push Sales: Fact MR prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.
AI-enabled design-and-test platform speeds bioproduct development
The ATEX-certified Inert Explosion-proof (INEX) pneumatic vacuum-conveying system (photo) features…
AI-enabled design-and-test platform speeds bioproduct development
By Mary Page Bailey |
May 1, 2021
TeselaGen Biotechnology (San Francisco, Calif.; www.teselagen.com) has developed a platform technology that integrates software and services, while taking advantage of artificial intelligence (AI) by applying machine-learning algorithms to reduce the costs and time required for the development of biologically derived products.
“Among the main challenges in biotechnology is that developing bioproducts can take years and cost millions of dollars,” says Eduardo Abeliuk, CEO of TeselaGen. “We think of ourselves as an operating system for biotech that allows the end-to-end integration of different AI-enabled software modules with other product development services.” As an analogy, Abeliuk likens the way his com
Credit: (Credit: Thor Swift/Berkeley Lab)
Plastics are a part of nearly every product we use on a daily basis. The average person in the U.S. generates about 100 kg of plastic waste per year, most of which goes straight to a landfill. A team led by Corinne Scown, Brett Helms, Jay Keasling, and Kristin Persson at Lawrence Berkeley National Laboratory (Berkeley Lab) set out to change that.
Less than two years ago, Helms announced the invention of a new plastic that could tackle the waste crisis head on. Called poly(diketoenamine), or PDK, the material has all the convenient properties of traditional plastics while avoiding the environmental pitfalls, because unlike traditional plastics, PDKs can be recycled indefinitely with no loss in quality.